Virtus LifeSci Biotech Clinical Trials ETF
BBC$43.90 +0.60 (1.37%)
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 29, 2025 | $0.66 | 2025-12-22 | 2025-12-22 |
| December 27, 2024 | $0.24 | 2024-12-20 | 2024-12-20 |
| December 29, 2023 | $0.08 | 2023-12-20 | 2023-12-21 |
| December 27, 2017 | $0.30 | 2017-12-20 | 2017-12-21 |
| December 29, 2015 | $0.15 | 2015-12-21 | 2015-12-23 |
Dividends Summary
- Consistent Payer: Virtus LifeSci Biotech Clinical Trials ETF has rewarded shareholders with 5 dividend payments over the past 10 years.
- Total Returned Value: Investors who held BBC shares during this period received a total of $1.42 per share in dividend income.
- Latest Payout: The most recent dividend of $0.66/share was paid 25 days ago, on December 29, 2025.
- Yield & Schedule: BBC currently pays dividends yearly with an annual yield of 1.49%.
- Dividend Growth: Since 2015, the dividend payout has grown by 344.9%, from $0.15 to $0.66.
Company News
5 Best ETF Areas of Last Week
Wall Street was mixed last week. The Nasdaq and the S&P 500 hit a new all-time high on the artificial intelligence boom and the Fed rate cut bets.
Top & Flop ETF Areas of Wall Street's Best February in Decade
Wall Street surged to close out February with the S&P 500 and Nasdaq Composite notching their best February since 2015.
This biotech ETF sees ‘breakout’ while U.S. small-cap technology stocks lag
This week’s ETF Wrap digs into the jump in biotech funds, as well as an “unusual” trend in U.S. small-cap stocks versus small-cap tech equities.
Best-Performing ETFs of Last Week
The S&P 500 hit a new high for the year last week after the November jobs report and University of Michigan consumer survey data indicated a resilient economy and cooling inflation, triggering bets on a so-called soft-landing scenario.
